有生育要求的卵巢子宫内膜异位囊肿药物治疗策略  

The drug treatment strategies of ovarian endometrioma with fertility requirements.

作　　者：刘晓琳 王立杰[1] LIU Xiaolin;WANG Li-jie(Department of Gynecology,Qilu Hospital,Shandong Uniersity,Jinan 250012,China)

机构地区：[1]山东大学齐鲁医院妇产科,山东济南250012

出　　处：《中国实用妇科与产科杂志》2024年第5期489-493,共5页Chinese Journal of Practical Gynecology and Obstetrics

基　　金：十四五国家重点研发计划“生育健康及妇女儿童健康保障”重点专项:子宫内膜异位症国家级数据平台建设和综合防治策略研究(2022YFC2704001)。

摘　　要：子宫内膜异位症是需要长期管理的慢性疾病,卵巢子宫内膜异位囊肿是最常见的子宫内膜异位症。症状以不孕和疼痛为主。子宫内膜异位症对卵巢储备功能的损害进行性加重。文章针对有生育要求的卵巢子宫内膜异位囊肿的诊断后治疗、手术后长期管理、复发后治疗、围生育期用药建议等分层阐述,强调了有生育要求患者的个体化药物治疗策略。Endometriosis is a kind of chronic disease that requires long-term management,with ovarian endometrioma as its most common subtype.The ovarian reserve can be progressively worsening with the disease progression,associated with pain and infertility.This article provides a detailed description of drug man⁃agement strategies for post-diagnosis treatment,longterm postoperative management,treatment after re⁃currence and perinatal medication recommendations for ovarian endometrioma,emphasizing individualized drug treatment strategies for patients with fertility re⁃quirements.

关 键 词：卵巢子宫内膜异位囊肿 不孕 痛经 药物 

分 类 号：R711.71[医药卫生—妇产科学]